Compugen (CGEN) Gross Profit (QoQ) (2012 - 2026)
Compugen (CGEN) Gross Profit (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551,658.73% |
| Dec 31, 2025 | -99.97% |
| Sep 30, 2025 | 159.07% |
| Jun 30, 2025 | -251.72% |
| Mar 31, 2025 | -114.57% |
| Dec 31, 2024 | -94.12% |
| Sep 30, 2024 | 162.74% |
| Jun 30, 2024 | 1,026.91% |
| Mar 31, 2024 | -98.55% |
| Dec 31, 2016 | 36,734,593.88% |
| Sep 30, 2016 | -88.05% |
| Jun 30, 2016 | 3,316.67% |
| Mar 31, 2016 | -99.84% |
| Dec 31, 2015 | 25,889.29% |
| Sep 30, 2015 | -62.67% |
| Jun 30, 2015 | -42.75% |
| Mar 31, 2015 | -97.65% |
| Dec 31, 2014 | 469.60% |
| Sep 30, 2014 | -11.58% |
| Jun 30, 2014 | -19.69% |